Showing results (491-500 of 593) with videos related to

Sort By:
Pageof 60
American Journal of Perinatology|September 19, 2023
Genetic Predisposition to Adverse Neurodevelopmental Outcome of Extremely Low Birth Weight InfantsMichael W Varner, Elizabeth A Thom, C Michael Cotten, et al.
The New England Journal of Medicine|August 13, 2015
A Randomized Trial of Intrapartum Fetal ECG ST-Segment AnalysisMichael A Belfort, George R Saade, Elizabeth Thom, et al.
American Journal of Perinatology|February 27, 2025
Association between Induction Start Time and Labor Duration in Nulliparous Women Undergoing Elective Induction of LaborFrancesca L Facco, Cora MacPherson, Uma M Reddy, et al.
American Journal of Obstetrics and Gynecology|September 23, 2023
Desirability of outcome ranking for obstetrical trials: illustration and application to the ARRIVE trialGrecio J Sandoval, William A Grobman, Scott R Evans, et al.
Obstetrics and Gynecology|December 2, 2021
Racial and Ethnic Inequities in Cesarean Birth and Maternal Morbidity in a Low-Risk, Nulliparous CohortMichelle P Debbink, Lynda G Ugwu, William A Grobman, et al.
American Journal of Perinatology|August 6, 2021
Serum Cotinine and Adverse Cardiovascular Outcomes: A Cross-sectional Secondary Analysis of the nuMoM2b Heart Health StudyLauren H Theilen, Rebecca B McNeil, Shannon Hunter, et al.
Pregnancy (Hoboken, N.J.)|April 27, 2026
A model to predict red blood cell transfusion during/after cesarean deliverySamuel Parry, Steven J Weiner, George R Saade, et al.
The New England Journal of Medicine|April 12, 2023
Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean DeliveryLuis D Pacheco, Rebecca G Clifton, George R Saade, et al.
Obstetrics and Gynecology|November 2, 2006
Comparison of serum markers in first-trimester down syndrome screeningJacob A Canick, Geralyn M Lambert-Messerlian, Glenn E Palomaki, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 20, 2021
Hypertension in pregnancy and adverse outcomes among low-risk nulliparous women expectantly managed at or after 39 weeks: a secondary analysis of a randomised controlled trialMichal Fishel Bartal, Ashish Premkumar, Madeline Murguia Rice, et al.
Pageof 60